Red Blood Cell Blood Group Antigens: Structure and Function

Seminars in Hematology

Volumn 41, Issue 2, 2004, Pages 93-117

  Reid, Marion E ^a   Mohandas, Narla ^a  

^a NEW YORK BLOOD CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; ERYTHROCYTE ANTIGEN; GLYCEROL; GLYCOPROTEIN; IMMUNOGLOBULIN; LIGAND; MEMBRANE ANTIGEN; MEMBRANE PROTEIN; UREA;

AMINO ACID SEQUENCE; ANION TRANSPORT; ANTIGEN EXPRESSION; ANTIGEN STRUCTURE; BACTERIUM; BLOOD GROUP ABO SYSTEM; BLOOD GROUP RHESUS SYSTEM; BLOOD GROUP SYSTEM; CELL MEMBRANE TRANSPORT; CELL SURFACE; ERYTHROCYTE MEMBRANE; GENE SEQUENCE; HOST PARASITE INTERACTION; HOST PATHOGEN INTERACTION; HUMAN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; SEQUENCE HOMOLOGY; VIRUS;

EID: 1942509539     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminhematol.2004.01.001     Document Type: Article

References (299)

1. Garratty G, Dzik WH, Issitt PD, et al: Terminology for blood group antigens and genes: Historical origins and guidelines in the new millennium. Transfusion 40:477-489, 2000
2. Daniels GL, Cartron JP, Fletcher A, et al: International Society of Blood Transfusion Committee on terminology for red cell surface antigens: Vancouver report. Vox Sang 84:244-247, 2003
3. Lögdberg L, Reid ME, Miller JL: Cloning and genetic characterization of blood group carrier molecules and antigens. Transfus Med Rev 16:1-10, 2002
4. Hoffman R, Benz EJ, Shattil SJ, et al (eds): Hematology: Basic Principles and Practice (ed 2). New York, NY, Churchill Livingstone, 1995
5. Alberts B, Bray D, Lewis J, et al: Molecular Biology of the Cell (ed 3). New York, NY, Garland, 1994
6. Walensky LD, Narla M, Lux SE: Disorders of the red blood cell membrane, in Handin RI, Lux SE, Stossel TP (eds): Blood: Principles and Practice of Hematology (ed 2). Philadelphia, PA, Lippincott Williams & Wilkins, 2003, pp 1709-1858
7. Telen MJ: Erythrocyte blood group antigens: Not so simple after all. Blood 85:299-306, 1995
8. Cartron JP, Colin Y: Structural and functional diversity of blood group antigens. Transfus Clin Biol 8:163-199, 2001
9. Paulson JC, Colley KJ: Glycosyltransferases. Structure, localization, and control of cell type-specific glycosylation. J Biol Chem 264:17615-17618, 1989
10. Mollison PL, Engelfriet CP, Contreras M: Blood Transfusion in Clinical Medicine (ed 10). Oxford, England, Blackwell Science, 1997
11. Anstee DJ, Spring FA: Red cell membrane glycoproteins with a broad tissue distribution. Transfus Med Rev 3:13-23, 1989
12. Southcott MJG, Tanner MJ, Anstee DJ: The expression of human blood group antigens during erythropoiesis in a cell culture system. Blood 93:4425-4435, 1999
13. Le Van Kim C, Piller V, Cartron JP, et al: Glycophorins C and D are generated by the use of alternative translation initiation sites. Blood 88:2364-2365, 1996
14. Cartron J-P, Le Van Kim C, Colin Y: Glycophorin C and related glycoproteins: Structure, function, and regulation. Semin Hematol 30:152-168, 1993
15. Reid ME, Spring FA: Molecular basis of glycophorin C variants and their associated blood group antigens. Transfus Med 4:139-149, 1994
16. Villeval JL, Le Van Kim C, Bettaieb A, et al: Early expression of glycophorin C during normal and leukemic human erythroid differentiation. Cancer Res 49:2626-2632, 1989
17. Chasis JA, Mohandas N: Red blood cell glycophorins. Blood 80:1869-1879, 1992
18. Hemming NJ, Anstee DJ, Mawby WJ, et al: Localisation of the protein 4.1-binding site on human erythrocyte glycophorins C and D. Biochem J 299:191-196, 1994
19. Nunomura W, Takakuwa Y, Parra M, et al: Regulation of protein 4.1R, p55, and glycophorin C ternary complex in human erythrocyte membrane. J Biol Chem 275:24540-24546, 2000
20. Reid ME, Chasis JA, Mohandas N: Identification of a functional role for human erythrocyte sialoglycoproteins beta and gamma. Blood 69:1068-1072, 1987
21. Reid ME, Takakuwa Y, Conboy J, et al: Glycophorin C content of human erythrocyte membrane is regulated by protein 4.1. Blood 75:2229-2234, 1990
22. Alloisio N, Dalla Venezia N, Rana A, et al: Evidence that red blood cell protein p55 may participate in the skeleton-membrane linkage that involves protein 4.1 and glycophorin C. Blood 82:1323-1327, 1993
23. Workman RF, Low PS: Biochemical analysis of potential sites for protein 4.1-mediated anchoring of the spectrinactin skeleton to the erythrocyte membrane. J Biol Chem 273:6171-6176, 1998
24. Hemming NJ, Anstee DJ, Staricoff MA, et al: Identification of the membrane attachment sites for protein 4.1 in the human erythrocyte. J Biol Chem 270:5360-5366, 1995
25. Marfatia SM, Morais-Cabral JH, Kim AC, et al: The PDZ domain of human erythrocyte p55 mediates its binding to the cytoplasmic carboxyl terminus of glycophorin C-Analysis of the binding interface by in vitro mutagenesis. J Biol Chem 272:24191-24197, 1997
26. Marfatia SM, Leu RA, Branton D, et al: Identification of the protein 4.1 binding interface on glycophorin C and p55, a homologue of the Drosophila discs-large tumor suppressor protein. J Biol Chem 270:715-719, 1995
27. Anstee DJ, Ridgwell K, Tanner MJ, et al: Individuals lacking the Gerbich blood-group antigen have alterations in the human erythrocyte membrane sialoglycoproteins beta and gamma. Biochem J 221:97-104, 1984
28. Le Van Kim C, Colin Y, Mitjavila MT, et al: Structure of the promoter region and tissue specificity of the human glycophorin C gene. J Biol Chem 264:20407-20414, 1989
29. Colin Y: Gerbich blood groups and minor glycophorins of human erythrocytes. Transfus Clin Biol 2:259-268, 1995
30. Reid ME, Anstee DJ, Jensen RH, et al: Normal membrane function of abnormal beta-related erythrocyte sialoglycoproteins. Br J Haematol 67:467-472, 1987
31. Chang S, Reid ME, Conboy J, et al: Molecular characterization of erythrocyte glycophorin C variants. Blood 77:644-648, 1991
32. Telen MJ, Le Van Kim C, Guizzo ML, et al: Erythrocyte Webb-type glycophorin C variant lacks N-glycosylation due to an asparagine to serine substitution. Am J Hematol 37:51-52, 1991
33. Telen MJ, Le Van Kim C, Chung A, et al: Molecular basis for elliptocytosis associated with glycophorin C and D deficiency in the Leach phenotype. Blood 78:1603-1606, 1991
34. Anstee DJ, Parsons SF, Ridgwell K, et al: Two individuals with elliptocytic red cells apparently lack three minor erythrocyte membrane sialoglycoproteins. Biochem J 218:615-619, 1984
35. Daniels GL, Shaw MA, Judson PA, et al: A family demonstrating inheritance of the Leach phenotype: A Gerbich-negative phenotype associated with elliptocytosis. Vox Sang 50:117-121, 1986
36. Nash GB, Parmar J, Reid ME: Effects of deficiencies of glycophorins C and D on the physical properties of the red cell. Br J Haematol 76:282-287, 1990
37. Marfatia SM, Lue RA, Branton D, et al: In vitro binding studies suggest a membrane-associated complex between erythroid p55, protein 4.1, and glycophorin C. J Biol Chem 269:8631-8634, 1994
38. Dhermy D, Garbarz M, Lecomte MC, et al: Hereditary elliptocytosis: Clinical, morphological and biochemical studies of 38 cases. Nouv Rev Fr Hematol 28:129-140, 1986
39. Dalla VN, Gilsanz F, Alloisio N, et al: Homozygous 4.1(-) hereditary elliptocytosis associated with a point mutation in the downstream initiation codon of protein 4.1 gene. J Clin Invest 90:1713-1717, 1992
40. Vince JW, Reithmeier RA: Structure of the band 3 transmembrane domain. Cell Mol Biol (Noisy-le-grand) 42:1041-1051, 1996
41. Jay DG: Role of band 3 in homeostasis and cell shape. Cell 86:853-854, 1996
42. Tanner MJA: The structure and function of band 3 (AE1): Recent developments. Mol Membr Biol 14:155-165, 1997
43. Popov M, Tam LY, Li J, et al: Mapping the ends of transmembrane segments in a polytopic membrane protein. Scanning N-glycosylation mutagenesis of extracytosolic loops in the anion exchanger, band 3. J Biol Chem 272:18325-18332, 1997
44. 854→Leu. J Biol Chem 269:16155-16158, 1994.
45. Bruce LJ, Ring SM, Anstee DJ, et al: Changes in the blood group Wright antigens are associated with a mutation at amino acid 658 in human erythrocyte band 3: A site of interaction between band 3 and glycophorin A under certain conditions. Blood 85:541-547, 1995
46. Harrison ML, Rathinavelu P, Arese P, et al: Role of band 3 tyrosine phosphorylation in the regulation of erythrocyte glycolysis. J Biol Chem 266:4106-4111, 1991
47. Jennings ML: Structure and function of the red blood cell anion transport protein. Annu Rev Biophys Biophys Chem 18:397-430, 1989
48. - exchanger. J Biol Chem 273:28430-28437, 1998
49. Lux SE, Palek J: Disorders of the red cell membrane, in Handin RI, Lux SE, Stossel TP (eds): Blood: Principles and Practice. Philadelphia, PA, Lippincott, 1995, pp 1701-1817
50. Bruce LJ, Tanner MJA: Structure-function relationships of band 3 variants. Cell Mol Biol 42:953-973, 1996
51. Delaunay J, Alloisio N, Morle L, et al: Molecular genetics of hereditary elliptocytosis and hereditary spherocytosis. Ann Genet 39:209-221, 1996
52. Hassoun H, Palek J: Hereditary spherocytosis: A review of the clinical and molecular aspects of the disease. Blood Rev 10:129-147, 1996
53. Wang DN, Kuhlbrandt W, Sarabia VE, et al: Two-dimensional structure of the membrane domain of human band 3, the anion transport protein of the erythrocyte membrane. EMBO J 12:2233-2239, 1993
54. Hassoun H, Hanada T, Lutchman M, et al: Complete deficiency of glycophorin A in red blood cells from mice with targeted inactivation of the band 3 (AE1) gene. Blood 91:2146-2151, 1998
55. Peters LL, Shivdasani RA, Liu SC, et al: Anion exchanger 1 (band 3) is required to prevent erythrocyte membrane surface loss but not to form the membrane skeleton. Cell 86:917-927, 1996
56. Inaba M, Yawata A, Koshino I, et al: Defective anion transport and marked spherocytosis with membrane instability caused by hereditary total deficiency of red cell band 3 in cattle due to a nonsense mutation. J Clin Invest 97:1804-1817, 1996
57. Liu SC, Zhai S, Palek J, et al: Molecular defect of the band 3 protein in southeast Asian ovalocytosis. N Engl J Med 323:1530-1538, 1990
58. Jarolim P, Palek J, Amato D, et al: Deletion in erythrocyte band 3 gene in malaria-resistant Southeast Asian ovalocytosis. Proc Natl Acad Sci USA 88:11022-11026, 1991
59. Mohandas N, Winardi R, Knowles D, et al: Molecular basis for membrane rigidity of hereditary ovalocytosis: A novel mechanism involving the cytoplasmic domain of band 3. J Clin Invest 89:686-692, 1992
60. Booth PB, Serjeantson S, Woodfield DG, et al: Selective depression of blood group antigens associated with hereditary ovalocytosis among Melanesians. Vox Sang 32:99-110, 1977
61. Sarabia VE, Casey JR, Reithmeier RA: Molecular characterization of the band 3 protein from Southeast Asian ovalocytes. J Biol Chem 268:10676-10680, 1993
62. Moriyama R, Ideguchi H, Lombardo CR, et al: Structural and functional characterization of band 3 from Southeast Asian ovalocytes. J Biol Chem 267:25792-25797, 1992
63. Smythe JS, Spring FA, Gardner B, et al: Monoclonal antibodies recognizing epitopes on the extracellular face and intracellular N-terminus of the human erythrocyte anion transporter (band 3) and their application to the analysis of South East Asian ovalocytes. Blood 85:2929-2936, 1995
64. Bruce LJ, Ring SM, Ridgwell K, et al: South-east Asian Ovalocytic (SAO) erythrocytes have a cold sensitive cation leak: Implications for studies of in vitro invasion of stored SAO red cells by Plasmodium falciparum malarial parasites. Blood 86:470a, 1995 (suppl 1, abstr)
65. Karet FE, Gainza FJ, Györy AZ, et al: Mutations in the chloride-bicarbonate exchanger gene AE1 cause autosomal dominant but not autosomal recessive distal renal tubular acidosis. Proc Natl Acad Sci USA 95;6337-6342, 1998
66. Bruce LJ, Tanner MJ: Erythroid band 3 variants and disease. Baillieres Best Pract Res Clin Haematol 12:637-654, 1999
67. Bruce LJ, Unwin RJ, Wrong O, et al: The association between familial distal renal tubular acidosis and mutations in the red cell anion exchanger (band 3, AE1) gene. Biochem Cell Biol 76:723-728, 1998
68. Tanphaichitr VS, Sumboonnanonda A, Ideguchi H, et al: Novel AE1 mutations in recessive distal renal tubular acidosis-Loss-of-function is rescued by glycophorin A. J Clin Invest 102:2173-2179, 1998
69. - exchanger. J Biol Chem 273:6380-6388, 1998
70. Bruce LJ, Cope DL, Jones GK, et al: Familial distal renal tubular acidosis is associated with mutations in the red cell anion exchanger (Band 3, AE1) gene. J Clin Invest 100:1693-1707, 1997
71. Waugh SM, Low PS: Hemichrome binding to band 3: Nucleation of Heinz bodies on the erythrocyte membrane. Biochemistry 24:34-39, 1985
72. Seah TG, Lew TW, Chin NM: A case of pseudohyperkalaemia and thrombocytosis. Ann Acad Med Singapore 27:442-443, 1998
73. Low PS: Structure and function of the cytoplasmic domain of band 3: Center of erythrocyte membrane-peripheral protein interactions. Biochim Biophys Acta 864:145-167, 1986
74. Rettig MP, Low PS, Gimm JA, et al: Evaluation of biochemical changes during in vivo erythrocyte senescence in the dog. Blood 93:376-384, 1999
75. Beppu M, Ando K, Kikugawa K: Poly-N-acetyllactosaminyl saccharide chains of band 3 as determinants for anti-band 3 autoantibody binding to senescent and oxidized erythrocytes. Cell Mol Biol (Noisy-le-grand) 42:1007-1024, 1996
76. Kay MM: Mechanism of removal of senescent cells by human macrophages in situ. Proc Natl Acad Sci USA 72:3521-3525, 1975
77. Ando K, Kikugawa K, Beppu M: Involvement of sialylated poly-N-acetyllactosaminyl sugar chains of band 3 glycoprotein on senescent erythrocytes in anti-band 3 autoantibody binding. J Biol Chem 269:19394-19398, 1994
78. Ando K, Kikugawa K, Beppu M: Induction of band 3 aggregation in erythrocytes results in anti-band 3 autoantibody binding to the carbohydrate epitopes of band 3. Arch Biochem Biophys 339:250-257, 1997
79. Schlüter K, Drenckhahn D: Co-clustering of denatured hemoglobin with band 3: its role in binding of autoantibodies against band 3 to abnormal and aged erythrocytes. Proc Natl Acad Sci USA 83:6137-6141, 1986
80. Kannan R, Labotka R, Low PS: Isolation and characterization of the hemichrome-stabilized membrane protein aggregates from sickle erythrocytes. Major site of autologous antibody binding. J Biol Chem 263:13766-13773, 1988
81. Turrini F, Mannu F, Arese P, et al: Characterization of the autologous antibodies that opsonize erythrocytes with clustered integral membrane proteins. Blood 81:3146-3152, 1993
82. Hornig R, Lutz HU: Band 3 protein clustering on human erythrocytes promotes binding of naturally occurring anti-band 3 and anti-spectrin antibodies. Exp Gerontol 35:1025-1044, 2000
83. Winograd E, Greenan JR, Sherman IW: Expression of senescent antigen on erythrocytes infected with a knobby variant of the human malaria parasite Plasmodium falciparum. Proc Natl Acad Sci USA 84:1931-1935, 1987
84. Giribaldi G, Ulliers D, Mannu F, et al: Growth of Plasmodium falciparum induces stage-dependent haemichrome formation, oxidative aggregation of band 3, membrane deposition of complement and antibodies, and phagocytosis of parasitized erythrocytes. BrJ Haematol 113:492-499, 2001
85. Ho M, Chelly J, Carter N, et al: Isolation of the gene for McLeod syndrome that encodes a novel membrane transport protein. Cell 77:869-880, 1994
86. Amara SG, Kuhar MJ: Neurotransmitter transporters: Recent progress. Ann Rev Neurosci 16:73-93, 1993
87. Khamlichi S, Bailly P, Blanchard D, et al: Purification and partial characterization of the erythrocyte Kx protein deficient in McLeod patients. Eur J Biochem 228:931-934, 1995
88. Russo D, Redman C, Lee S: Association of XK and Kell blood group proteins. J Biol Chem 273:13950-13956, 1998
89. Symmans WA, Shepherd CS, Marsh WL, et al: Hereditary acanthocytosis associated with the McLeod phenotype of the Kell blood group system. Br J Haematol 42:575-583, 1979
90. Taswell HF, Lewis JC, Marsh WL, et al: Erythrocyte morphology in genetic defects of the Rh and Kell blood group systems. Mayo Clin Proc 52:157-159, 1977
91. Wimer BM, Marsh WL, Taswell HF, et al: Haematological changes associated with the McLeod phenotype of the Kell blood group system. Br J Haematol 36:219-224, 1977
92. Redman CM, Huima T, Robbins E, et al: Effect of phosphatidylserine on the shape of McLeod red cell acanthocytes. Blood 74:1826-1835, 1989
93. Danek A, Uttner I, Vogl T, et al: Cerebral involvement in McLeod syndrome. Neurology 44:117-120, 1994
94. Marsh WL, Marsh WL, Marsh NJ, Moore A, et al: Elevated serum creatine phosphokinase in subjects with McLeod syndrome. Vox Sang 40:403-411, 1981
95. Malandrini A, Fabrizi GM, Truschi F, et al: Atypical McLeod syndrome manifested as X-linked chorea-acanthocytosis, neuromyopathy and dilated cardiomyopathy: Report of a family. J Neurol Sci 124:89-94, 1994
96. Takashima H, Sakai T, Iwashita H, et al: A family of McLeod syndrome, masquerading as chorea-acanthocytosis. J Neurol Sci 124:56-60, 1994
97. Jung HH, Hergersberg M, Kneifel S, et al: McLeod syndrome: A novel mutation, predominant psychiatric manifestations, and distinct striatal imaging findings. Ann Neurol 49:384-392, 2001
98. Kawakami T, Takiyama Y, Yoshioka T, et al: A case of McLeod syndrome with unusually severe myopathy. J Neurol Sci 166:36-39, 1999
99. Alper SL, Kopito RR, Libresco SM, et al: Cloning and characterization of a murine band 3-related cDNA from kidney and from a lymphoid cell line. J Biol Chem 263:17092-17099, 1988
100. Bruce LJ, Kay MM, Lawrence C, et al: Band 3 HT, a human red-cell variant associated with acanthocytosis and increased anion transport, carries the mutation Pro-868→Leu in the membrane domain of band 3. Biochem J 293:317-320, 1993
101. Marsh WL, Redman CM: Recent developments in the Kell blood group system. Transfus Med Rev 1:4-20, 1987
102. Redman CM, Marsh WL: The Kell blood group system and the McLeod phenotype. Semin Hematol 30:209-218, 1993
103. Sorrentino G, De Renzo A, Miniello S, et al: Late appearance of acanthocytes during the course of chorea-acanthocytosis. J Neurol Sci 163:175-178, 1999
104. Hardie RJ: Acanthocytosis and neurological impairment - A review. Q J Med 71:291-306, 1989
105. Swash M, Schwartz MS, Carter ND, et al: Benign X-linked myopathy with acanthocytes (McLeod syndrome). Its relationship to X-linked muscular dystrophy. Brain 106:717-733, 1983
106. Barnett MH, Yang F, Iland H, et al: Unusual muscle pathology in McLeod syndrome. J Neurol Neurosurg Psychiatry 69:655-657, 2000
107. Lee S, Russo D, Redman CM: The Kell blood group system: Kell and XK membrane proteins. Semin Hematol 37:113-121, 2000
108. Redman CM, Russo D, Lee S: Kell, Kx and the McLeod syndrome. Baillieres Best Pract Res Clin Haematol 12:621-635, 1999
109. Glaubensklee CS, Evan AP, Galey WR: Structural and biochemical analysis of the Mcleod erythrocyte membrane. I. Freeze fracture and discontinuous polyacrylamide gel electrophoresis analysis. Vox Sang 42:262-271, 1982
110. Casey JR, Reithmeier RA: Analysis of the oligomeric state of band 3, the anion transport protein of the human erythrocyte membrane, by size exclusion high performance liquid chromatography. Oligomeric stability and origin of heterogeneity. J Biol Chem 266:15726-15737, 1991
111. Jung HH, Russo D, Redman C, et al: Kell and XK immunohistochemistry in McLeod myopathy. Muscle Nerve 24:1346-1351, 2001
112. Danek A, Rubio JP, Rampoldi L, et al: McLeod neuroacanthocytosis: Genotype and phenotype. Ann Neurol 50:755-764, 2001
113. Avent ND, Reid ME: The Rh blood group system: A review. Blood 95:375-387, 2000
114. Huang C-H, Liu PZ, Cheng JG: Molecular biology and genetics of the Rh blood group system. Semin Hematol 37:150-165, 2000
115. Marini AM, Matassi G, Raynal V, et al: The human rhesus-associated RhAG protein and a kidney homologue promote ammonium transport in yeast. Nature Genet 26:341-344, 2000
116. + transporters. Trends Biochem Sci 22:460-461, 1997
117. Soupene E, Ramirez RM, Kustu S: Evidence that fungal MEP proteins mediate diffusion of the uncharged species NH(3) across the cytoplasmic membrane. Mol Cell Biol 21:5733-5741, 2001
118. Huang CH, Liu PZ: New insights into the Rh superfamily of genes and proteins in erythroid cells and nonerythroid tissues. Blood Cells Mol Dis 27:90-101, 2001
119. Westhoff CM, Ferreri-Jacobia M, Mak D-OD, et al: Identification of the erythrocyte Rh blood group glycoprotein as a mammalian ammonium transporter. J Biol Chem 277:12499-12502, 2002
120. Soupene E, King N, Feild E, et al: Rhesus expression in a green alga is regulated by CO2. Proc Natl Acad Sci USA 99:7769-7773, 2002
121. null disease. Vox Sang 23:182-189, 1972
122. Ballas SK, Clark MR, Mohandas N, et al: Red cell membrane and cation deficiency in Rh null syndrome. Blood 63:1046-1055, 1984
123. Sturgeon P: Hematological observations on the anemia associated with blood type Rhnull. Blood. 36:310-320, 1970
124. Lauf PK, Joiner CH: Increased potassium transport and ouabain binding in human Rhnull red blood cells. Blood 48:457-468, 1976
125. Heaton DC, McLoughlin K: Jk(a-b-) red blood cells resist urea lysis. Transfusion 22:70-71, 1982
126. Olivès B, Mattei M-G, Huet M, et al: Kidd blood group and urea transport function of human erythrocytes are carried by the same protein. J Biol Chem 270:15607-15610, 1995
127. Olivès B, Neau P, Bailly P, et al: Cloning and functional expression of a urea transporter from human bone marrow cells. J Biol Chem 269:31649-31652, 1994
128. Macey RI, Yousef LW: Osmotic stability of red cells in renal circulation requires rapid urea transport. Am J Physiol 254: C669-C674, 1988
129. Frohlich O, Macey RI, Edwards-Moulds J, et al: Urea transport deficiency in Jk(a-b-) erythrocytes. Am J Physiol 260:C778-C783, 1991
130. Sands JM, Gargus JJ, Frohlich O, et al: Urinary concentrating ability in patients with Jk(a-b-) blood type who lack carrier-mediated urea transport. J Am Soc Nephrol 2:1689-1696, 1992
131. null individuals. J Biol Chem 273:12973-12980, 1998
132. Irshaid NM, Henry SM, Olsson ML: Genomic characterization of the Kidd blood group gene: Different molecular basis of the Jk(a-b-) phenotype in Polynesians and Finns. Transfusion 40:69-74, 2000
133. Zeidel ML, Ambudkar SV, Smith BL, et al: Reconstitution of functional water channels in liposomes containing purified red cell CHIP28 protein. Biochemistry 31:7436-7440, 1992
134. Nielsen S, Smith BL, Christensen EI, et al: CHIP28 water channels are localized in constitutively water-permeable segments of the nephron. J Cell Biol 120:371-383, 1993
135. Smith BL, Baumgarten R, Nielsen S, et al: Concurrent expression of erythroid and renal aquaporin CHIP and appearance of water channel activity in perinatal rats. J Clin Invest 92:2035-2041, 1993
136. Preston GM, Carroll TP, Guggino WB, et al: Appearance of water channels in Xenopus oocytes expressing red cell CHIP28 protein. Science 256:385-387, 1992
137. Preston GM, Agre P: Isolation of the cDNA for erythrocyte integral membrane protein of 28 kilodaltons: Member of an ancient channel family. Proc Natl Acad Sci USA 88:11110-11114, 1991
138. Sui H, Han BG, Lee JK, et al: Structural basis of water-specific transport through the AQP1 water channel. Nature 414:872-878, 2001
139. Preston GM, Smith BL, Zeidel ML, et al: Mutations in aquaporin-1 in phenotypically normal humans without functional CHIP water channels. Science 265:1585-1587, 1994
140. Cartron JP, Bailly P, Le Van Kim C, et al: Insights into the structure and function of membrane polypeptides carrying blood group antigens. Vox Sang 74:29-64, 1998 (suppl 2)
141. King LS, Choi M, Fernandez PC, et al: Defective urinary-concentrating ability due to a complete deficiency of aquaporin-1. N Engl J Med 345:175-179, 2001
142. King LS, Nielsen S, Agre P, et al: Decreased pulmonary vascular permeability in aquaporin-1-null humans. Proc Natl Acad Sci USA 99:1059-1063, 2002
143. Ma T, Yang B, Gillespie A, et al: Severely impaired urinary concentrating ability in transgenic mice lacking aquaporin-1 water channels. J Biol Chem 273:4296-4299, 1998
144. Roudier N, Verbavatz JM, Maurel C, et al: Evidence for the presence of aquaporin-3 in human red blood cells. J Biol Chem 273:8407-8412, 1998
145. Ishibashi K, Sasaki S, Fushimi K, et al: Molecular cloning and expression of a member of the aquaporin family with permeability to glycerol and urea in addition to water expressed at the basolateral membrane of kidney collecting duct cells. Proc Natl Acad Sci USA 91:6269-6273, 1994
146. Daniels GL, Delong EN, Hare V, et al: GIL: A red cell antigen of very high frequency. Immunohematology 14:49-52, 1998
147. Roudier N, Ripoche P, Gane P, et al: AQP3 deficiency in humans and the molecular basis of a novel blood group system, GIL. J Biol Chem 277:45854-45859, 2002
148. Roudier N, Bailly P, Gane P, et al: Erythroid expression and oligomeric state of the AQP3 protein. J Biol Chem 277:7664-7669, 2002
149. b blood group polymorphism. Hum Genet 95:407-410, 1995
150. Pogo AO, Chaudhuri A: The Duffy protein: A malarial and chemokine receptor. Semin Hematol 37:122-129, 2000
151. Darbonne WC, Rice GC, Mohler MA, et al: Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin. J Clin Invest 88:1362-1369, 1991
152. Neote K, Darbonne W, Ogez J, et al: Identification of a promiscuous inflammatory peptide receptor on the surface of red blood cells. J Biol Chem 268:12247-12249, 1993
153. Horuk R, Colby TJ, Darbonne WC, et al: The human erythrocyte inflammatory peptide (chemokine) receptor. Biochemical characterization, solubilization, and development of a binding assay for the soluble receptor. Biochemistry 32:5733-5738, 1993
154. Tournamille C, Filipe A, Wasniowska K, et al: Structure/function analysis of the extracellular domains of the Duffy antigen/receptor for chemokines: Characterization of antibody and chemokine binding sites. BrJ Haematol 122:1014-1023, 2003
155. Chaudhuri A, Polyakova J, Zbrzezna V, et al: Cloning of glycoprotein D cDNA, which encodes the major subunit of the Duffy blood group system and the receptor for the Plasmodium vivax malaria parasite. Proc Natl Acad Sci USA 90:10793-10797, 1993
156. Miller LH, Mason SJ, Clyde DF, et al: The resistance factor to Plasmodium vivax in blacks. The Duffy blood group genotype, FyFy. N Engl J Med 295:302, 1976
157. Hadley TJ, Peiper SC: From malaria to chemokine receptor: The emerging physiologic role of the Duffy blood group antigen. Blood 89:3077-3091, 1997
158. Hamblin MT, Di Rienzo A: Detection of the signature of natural selection in humans: Evidence from the Duffy blood group locus. Am J Hum Genet 66:1669-1679, 2000
159. Tournamille C, Colin Y, Cartron JP, et al: Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nature Genet 10:224-228, 1995
160. Akalin E, Neylan JF: The influence of Duffy blood group on renal allograft outcome in African Americans. Transplantation 75:1496-1500, 2003
161. null in a Plasmodium vivax-endemic region of Papua New Guinea. Proc Natl Acad Sci USA 96:13973-13977, 1999
162. b antigens and identification of a deletion in the Duffy gene of an apparently healthy individual with the Fy(a-b-) phenotype: BrJ Haematol 90:823-829, 1995
163. Rios M, Chaudhuri A, Mallinson G, et al: New genotypes in Fy(a-b-) individuals: Nonsense mutations (Trp to stop) in the coding sequence of either FY A or FY B. Br J Haematol 108:448-454, 2000
164. Luo H, Chaudhuri A, Zbrzezna V, et al: Deletion of the murine Duffy gene (Dfy) reveals that the Duffy receptor is functionally redundant. Mol Cell Biol 20:3097-3101, 2000
165. Dawson TC, Lentsch AB, Wang Z, et al: Exaggerated response to endotoxin in mice lacking the Duffy antigen/receptor for chemokines (DARC). Blood 96:1681-1684, 2000
166. Abboud MR, Taylor EC, Habib D, et al: Elevated serum and bronchoalveolar lavage fluid levels of interleukin 8 and granulocyte colony-stimulating factor associated with the acute chest syndrome in patients with sickle cell disease. Br J Haematol 111:482-490, 2000
167. Jilma-Stohlawetz P, Homoncik M, Drucker C, et al: Fy phenotype and gender determine plasma levels of monocyte chemotactic protein. Transfusion 41:378-381, 2001
168. Parasol N, Reid M, Rios M, et al: A novel mutation in the coding sequence of the FY*B allele of the Duffy chemokine receptor gene is associated with an altered erythrocyte phentoype. Blood 92:2237-2243, 1998
169. b allele predicting Arg89Cys in the Duffy glycoprotein. Br J Haematol 103:1184-1191, 1998
170. x individuals. Blood 92:2147-2156, 1998
171. Tournamille C, Le Van KC, Gane P, et al: Arg89Cys substitution results in very low membrane expression of the Duffy antigen/receptor for chemokines in Fy(x) individuals. Blood 92:2147-2156, 1998
172. Lee JS, Frevert CW, Wurfel MM, et al: Duffy antigen facilitates movement of chemokine across the endothelium in vitro and promotes neutrophil transmigration in vitro and in vivo. J Immunol 170:5244-5251, 2003
173. Lee JS, Frevert CW, Thorning DR, et al: Enhanced expression of Duffy antigen in the lungs during suppurative pneumonia. J Histochem Cytochem 51:159-166, 2003
174. Irimura T, Tsuji T, Tagami S, et al: Structure of a complex-type sugar chain of human glycophorin A. Biochemistry 20:560-566, 1981
175. Gahmberg CG, Andersson LC: Role of sialic acid in the mobility of membrane proteins containing O-linked oligosaccharides on polyacrylamide gel electrophoresis in sodium dodecyl sulfate. Eur J Biochem 122:581-586, 1982
176. Morrow B, Rubin CS: Biogenesis of glycophorin A in K562 human erythroleukemia cells. J Biol Chem 262:13812-13820, 1987
177. 31P nuclear magnetic resonance evidence for polyphosphoinositide associated with the hydrophobic segment of glycophorin A. Biochemistry 16:1317-1320, 1977
178. Mendelsohn R, Dluhy RA, Crawford T, et al: Interaction of glycophorin with phosphatidylserine: A Fourier transform infrared investigation. Biochemistry 23:1498-1504, 1984
179. Smith SO, Bormann BJ: Determination of helix-helix interactions in membranes by rotational resonance NMR. Proc Natl Acad Sci USA 92:488-491, 1995
180. Brosig B, Langosch D: The dimerization motif of the glycophorin A transmembrane segment in membranes: Importance of glycine residues. Protein Sci 7:1052-1056, 1998
181. MacKenzie KR, Prestegard JH, Engelman DM: A transmembrane helix dimer: Structure and implications. Science 276:131-133, 1997
182. b expression. Transfus Med 9:167-174, 1999
183. Groves JD, Tanner MJ: Glycophorin A facilitates the expression of human band 3-mediated anion transport in Xenopus oocytes. J Biol Chem 267:22163-22170, 1992
184. Chasis JA, Mohandas N, Shohet SB: Erythrocyte membrane rigidity induced by glycophorin A-ligand interaction. Evidence for a ligand-induced association between glycophorin A and skeletal proteins. J Clin Invest 75:1919-1926, 1985
185. Chasis JA, Reid ME, Jensen RH, et al: Signal transduction by glycophorin A: Role of extracellular and cytoplasmic domains in a modulatable process. J Cell Biol 107:1351-1357, 1988
186. Andersson LC, Gahmberg CG, Teerenhovi L, et al: Glycophorin A as a cell surface marker of early erythroid differentiation in acute leukemia. Int J Cancer 24:717-720, 1979
187. Langlois RG, Bigbee WL, Kyoizumi S, et al: Evidence for increased somatic cell mutations at the glycophorin A locus in atomic bomb survivors. Science 236:445-448, 1987
188. Kyoizumi S, Nakamura N, Hakoda M, et al: Detection of somatic mutations at the glycophorin A locus in erythrocytes of atomic bomb survivors using a
189. Reid ME, Lomas-Francis CBlood Group Antigen FactsBook (ed 2). San Diego, CA, Academic Press, 2003
190. Telen MJ, Chasis JA: Relationship of the human erythrocyte Wrb antigen to an interaction between glycophorin A and band 3. Blood 76:842-848, 1990
191. Knowles DW, Chasis JA, Evans EA, et al: Cooperative action between band 3 and glycophorin A in human erythrocytes: Immobilization of band 3 induced by antibodies to glycophorin A. Biophys J 66:1726-1732, 1994
192. Siebert PD, Fukuda M: Molecular cloning of a human glycophorin B cDNA: Nucleotide sequence and genomic relationship to glycophorin A. Proc Natl Acad Sci USA 84:6735-6739, 1987
193. Rearden A, Magnet A, Kudo S, et al: Glycophorin B and glycophorin E genes arose from the glycophorin A ancestral gene via two duplications during primate evolution. J Biol Chem 268:2260-2267, 1993
194. Furthmayr H: Structural comparison of glycophorins and immunochemical analysis of genetic variants. Nature 271:519-524, 1978
195. Rahuel C, Vinit MA, Lemarchandel V, et al: Erythroid-specific activity of the glycophorin B promoter requires GATA-1 mediated displacement of a repressor. EMBO J 11:4095-4102, 1992
196. Camara-Clayette V, Thomas D, Rahuel C, et al: The repressor which binds the -75 GATA motif of the GPB promoter contains Ku70 as the DNA binding subunit. Nucleic Acids Res 27:1656-1663, 1999
197. Tanner MJA, Anstee DJ, Judson PA: A carbohydrate-deficient membrane glycoprotein in human erythrocytes of phenotype S-s-. Biochem J 165:157-161, 1977
198. Tokunaga E, Sasakawa S, Tamaka K, et al: Two apparently healthy Japanese individuals of type MkMk have erythrocytes which lack both the blood group MN and Ss-active sialoglycoproteins. J Immunogenet 6:383-390, 1979
199. Perkins M: Inhibitory effects of erythrocyte membrane proteins on the in vitro invasion of the human malarial parasite (Plasmodium falciparum) into its host cell. J Cell Biol 90:563-567, 1981
200. Pasvol G, Jungery M, Weatherall DJ, et al: Glycophorin as a possible receptor for Plasmodium falciparum. Lancet 2:947-950, 1982
201. Dolan SA, Miller LH, Wellems TE: Evidence for a switching mechanism in the invasion of erythrocytes by Plasmodium falciparum. J Clin Invest 86:618-624, 1990
202. Orlandi PA, Klotz FW, Haynes JD: A malaria invasion receptor, the 175-kilodalton erythrocyte binding antigen of Plasmodium falciparum recognizes the terminal Neu5Ac(alpha 2- 3)Gal-sequences of glycophorin A. J Cell Biol 116:901-909, 1992
203. Dolan SA, Proctor JL, Alling DW, et al: Glycophorin B as an EBA-175 independent Plasmodium falciparum receptor of human erythrocytes. Mol Biochem Parasitol 64:55-63, 1994
204. Tippett P, Storry JR, Walker PS, et al: Glycophorin A-deficient red cells may have a weak expression of C4-bound Ch and Rg antigens. Immunohematology 12:4-7, 1996
205. Tomita A, Radike EL, Parker CJ: Isolation of erythrocyte membrane inhibitor of reactive lysis type II. Identification as glycophorin A. J Immunol 151:3308-3323, 1993
206. el Ouagari K, Teissie J, Benoist H: Glycophorin A protects K562 cells from natural killer cell attack. Role of oligosaccharides. J Biol Chem 270:26970-26975, 1995
207. Weber GF, Ashkar S, Glimcher MJ, et al: Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 271:509-512, 1996
208. Verfaillie CM, Benis A, Iida J, et al: Adhesion of committed human hematopietic progenitors to synthetic peptides from the C-terminal heparin-binding domain of fibronectin: Cooperation between the integrin alpha 4 beta 1 and the CD44 adhesion receptor. Blood 84:1802-1811, 1994
209. Gee B, Platt OS: CD44 may be a laminin receptor of normal and sickle erythrocytes. Blood 86:137a(suppl 1, abstr), 1995
210. Goodison S, Urquidi V, Tarin D: CD44 cell adhesion molecules. J Clin Pathol Mol Pathol 52:189-196, 1999
211. Ristamaki R, Joensuu H, Lappalainen K, et al: Elevated serum CD44 level is associated with unfavorable outcome in non- Hodgkin's lymphoma. Blood 90:4039-4045, 1997
212. Parsons SF, Jones J, Anstee DJ, et al: A novel form of congenital dyserythropoietic anemia associated with deficiency of erythroid CD44 and a unique blood group phenotype [In(a-b-), Co(a-b-)]. Blood 83:860-868, 1994
213. 2+ and calmodulin. Implications for modulation of CD44-ankyrin interaction. J Biol Chem 272:30322-30328, 1997
214. Nunomura W, Takakuwa Y, Parra M, et al: Ca(2+)-dependent and Ca(2+)-independent calmodulin binding sites in erythrocyte protein 4.1. Implications for regulation of protein 4.1 interactions with transmembrane proteins. J Biol Chem 275:6360-6367, 2000
215. Williams AF, Barclay AN: The immunoglobulin superfamily - Domains for cell surface recognition. Ann Rev Immunol 6:381-405, 1988
216. Barclay AN, Brown MH, Law SKA, et al: Leucocyte Antigen Facts Book (ed 2). San Diego, CA, Academic Press, 1997
217. b blood group antigen is located on red cell membrane glycoproteins of 85 and 78 kd. Transfusion 27:61-63, 1987
218. b polymorphisms: Blood 89:4219-4225, 1997
219. Parsons SF, Mallinson G, Holmes CH, et al: The Lutheran blood group glycoprotein, another member of the immunoglobulin superfamily, is widely expressed in human tissues and is developmentally regulated in human liver. Proc Natl Acad Sci USA 92:5496-5500, 1995
220. Rahuel C, Kim CL, Mattei MG, et al: A unique gene encodes spliceoforms of the B-cell adhesion molecule cell surface glycoprotein of epithelial cancer and of the Lutheran blood group glycoprotein. Blood 88:1865-1872, 1996
221. b blood group polymorphism. Blood 89:4608-4616, 1997
222. Udani M, Zen Q, Cottman M, et al: Basal cell adhesion molecule Lutheran protein - The receptor critical for sickle cell adhesion to laminin. J Clin Invest 101:2550-2558, 1998
223. Zen Q, Cottman M, Truskey G, et al: Critical factors in basal cell adhesion molecule/Lutheran-mediated adhesion to laminin. J Biol Chem 274:728-734, 1999
224. El Nemer W, Gane P, Colin Y, et al: The Lutheran blood group glycoproteins, the erythroid receptors for laminin, are adhesion molecules. J Biol Chem 273:16686-16693, 1998
225. Southcott MJG, Parsons SF, Anstee DJ, et al: Lutheran glycoprotein, a cell adhesion molecule that binds laminin with high affinity, is expressed on late erythrocyte precursors and appears after band 3. Blood 90:175b(suppl 2, abstr), 1997
226. Moulson CL, Li C, Miner JH: Localization of Lutheran, a novel laminin receptor, in normal, knockout, and transgenic mice suggests an interaction with laminin a5 in vivo. Develop Dynam 222:101-114, 2001
227. Kikkawa Y, Moulson CL, Virtanen I, et al: Identification of the binding site for the Lutheran blood group glycoprotein on laminin alpha 5 through expression of chimeric laminin chains in vivo. J Biol Chem 277:44864-44869, 2002
228. Bolcato-Bellemin AL, Lefebvre O, Arnold C, et al: Laminin alpha 5 chain is required for intestinal smooth muscle development. Dev Biol 260:376-390, 2003
229. Parsons SF, Lee G, Spring FA, et al: Lutheran blood group glycoprotein and its newly characterized mouse homologue specifically bind α5 chain-containing human laminin with high affinity. Blood 97:312-320, 2001
230. Mallinson G, Green CA, Okubo Y, et al: The molecular background of recessive Lu(a-b-) phenotype in a Japanese family. Transfus Med 7:18(suppl 1, abstr), 1997
231. Udden MM, Umeda M, Hirano Y, et al: New abnormalities in the morphology, cell surface receptors, and electrolyte metabolism of In(Lu) erythrocytes. Blood 69:52-57, 1987
232. Shaw MA, Leak MR, Daniels GL, et al: The rare Lutheran blood group phenotype Lu(a-b-): A genetic study. Ann Hum Genet 48:229-237, 1984
233. Telen MJ: The Lutheran antigens and proteins affected by Lutheran regulatory genes, in Agre PC, Cartron J-P (eds): Protein Blood Group Antigens of the Human Red Cell: Structure, Function, and Clinical Significance. Baltimore, MD, Johns Hopkins University Press, 1992, pp 70-87
234. Telen MJ, Eisenbarth GS, Haynes BF: Human erythrocyte antigens. Regulation of expression of a novel erythrocyte surface antigen by the inhibitor Lutheran In(Lu) gene. J Clin Invest 71:1878-1886, 1983
235. Bailly P, Hermand P, Callebaut I, et al: The LW blood group glycoprotein is homologous to intercellular adhesion molecules. Proc Natl Acad Sci USA 91:5306-5310, 1994
236. Bailly P, Tontti E, Hermand P, et al: The red cell LW blood group protein is an intercellular adhesion molecule which binds to CD11/CD18 leukocyte integrins. Eur J Immunol 25:3316-3320, 1995
237. v-family integrins through novel integrin-binding mechanisms. Blood 98:458-466, 2001
238. Southgate CD, Chishti AH, Mitchell B, et al: Targeted disruption of the murine erythroid band 3 gene results in spherocytosis and severe haemolytic anaemia despite a normal membrane skeleton. Nature Genet 14:227-230, 1996
239. Lee G, Spring FA, Parsons SF, et al: Novel secreted isoform of adhesion molecule ICAM-4: Potential regulator of membrane-associated ICAM-4 interactions. Blood 101:1790-1797, 2003
240. 3 integrin. J Biol Chem 278:4892-4898, 2003
241. Spring FA, Persons SF, Orthepp S, et al: Intercellular adhesion molecule-4 binds alpha(4)beta(1)-family integrins through novel integrin-binding mechanisms. Blood 98:458-466, 2001
242. - phenotypes. Blood 87:2962-2967, 1996
243. Giles CM: The LW blood group: A review. Immunol Commun 9:225-242, 1980
244. Kanekura T, Miyauchi T, Tashiro M, et al: Basigin, a new member of the immunoglobulin superfamily: Genes in different mammalian species, glycosylation changes in the molecule from adult organs and possible variation in the N-terminal sequences. Cell Struct Funct 16:23-30, 1991
245. a blood group antigen is a marker for the M6 leukocyte activation antigen, the human homolog of OX-47 antigen, basigin and neurothelin, an immunoglobulin superfamily molecule that is widely expressed in human cells and tissues. EurJ Immunol 27:891-897, 1997
246. Kasinrerk W, Fiebiger E, Stefanova I, et al: Human leukocyte activation antigen M6, a member of the Ig superfamily, is the species homologue of rat OX-47, mouse basigin, and chicken HT7 molecule. J Immunol 149:847-854, 1992
247. Igakura T, Kadomatsu K, Kaname T, et al: A null mutation in basigin, an immunoglobulin superfamily member, indicates its important roles in peri-implantation development and spermatogenesis. Dev Biol 194:152-165, 1998
248. Yuasa J, Toyama Y, Miyauchi T, et al: Specific localization of the basigin protein in human testes from normal adults, normal juveniles, and patients with azoospermia. Andrologia 33:293-299, 2001
249. Heller M, von der OM, Kleene R, et al: The immunoglobulin-superfamily molecule basigin is a binding protein for oligomannosidic carbohydrates: An anti-idiotypic approach. J Neurochem 84:557-565, 2003
250. Wagner FF, Poole J, Flegel WA: The Scianna antigens including Rd are expressed by ERMAP. Blood 101:752-757, 2003
251. Xu H, Foltz L, Sha Y, et al: Cloning and characterization of human erythroid membrane-associated protein, human ERMAP. Genomics 76:2-4, 2001
252. Su YY, Gordon CT, Ye TZ, et al: Human ERMAP: An erythroid adhesion/receptor transmembrane protein. Blood Cells Mol Dis 27:938-949, 2001
253. Ellis NA, Ye TZ, Patton S, et al: Cloning of PBDX, an MIC2-related gene that spans the pseudoautosomal boundary on chromosome Xp. Nature Genet 6:394-400, 1994
254. Ellis NA, Tippett P, Petty A, et al: PBDX is the XG blood group gene. Nature Genet 8:285-290, 1994
255. Bernard G, Breittmayer JP, de Matteis M, et al: Apoptosis of immature thymocytes mediated by E2/CD99. J Immunol 158:2543-2550, 1997
256. Tippett P, Ellis NA: The Xg blood group system: A review. Transf Med Rev 12:233-257, 1998
257. Angelisova P, Drbal K, Cerny J, et al: Characterization of the human leukocyte GPI-anchored glycoprotein CDw108 and its relation to other similar molecules. Immunobiology 200:234-245, 1999
258. Mudad R, Rao N, Angelisova P, et al: Evidence of CDw108 membrane protein bears the JMH blood group antigen. Transfusion 35:566-570, 1995
259. Lee S, Zambas E, Green ED, et al: Organization of the gene encoding the human Kell blood group protein. Blood 85:1364-1370, 1995
260. Lee S, Lin M, Mele A, et al: Proteolytic processing of big endothelin-3 by the Kell blood group protein. Blood 94:1440-1450, 1999
261. Lee S, Russo D, Redman C: Functional and structural aspects of the Kell blood group system. Transfus Med Rev 14:93-103, 2000
262. Lee S, Wu X, Reid ME, et al: Molecular basis of the Kell (K1) phenotype. Blood 85:912-916, 1995
263. a blood group antigen and is reduced or absent in the Yt(a-b-) phenotype. Blood 81:815-819, 1993
264. Spring FA, Gardner B, Anstee DJ: Evidence that the antigens of the Yt blood group system are located on human erythrocyte acetylcholinesterase. Blood 80:2136-2141, 1992
265. Bartels CF, Zelinski T, Lockridge O: Mutation at codon 322 in the human acetylcholinesterase (ACHE) gene accounts for YT blood group polymorphism. Am J Hum Genet 52:928-936, 1993
266. Koch-Nolte F, Haag F: Mono (ADP-ribosyl) transferases and related enzymes in animal tissues, in Haag F, Koch-Nolte F (eds): ADP Ribosylation in Animal Tissues: Structure, Function, and Biology of Mono (ADP-Ribosyl) Transferases and Related Enzymes. New York, NY, Plenum, 1997, pp 1-13
267. Gubin AN, Njoroge JM, Wojda U, et al: Identification of the Dombrock blood group glycoprotein as a polymorphic member of the ADP-ribosyltransferase gene family. Blood 96:2621-2627, 2000
268. Reid ME: The Dombrock blood group system: A review. Transfusion 43:107-114, 2003
269. Lublin DM, Kompelli S, Storry JR, et al: Molecular basis of Cromer blood group antigens. Transfusion 40:208-213, 2000
270. Storry JR, Sausais L, Roye-Hue K, et al: GUTI: A new antigen in the Cromer blood group system. Transfusion 43:340-344, 2003
271. Holmes CH, Simpson KL, Okada H, et al: Complement regulatory proteins at the feto-maternal interface during human placental development: Distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating factor (CD55). Eur J Immunol 22:1579-1585, 1992
272. Nowicki B, Hart A, Coyne KE, et al: Short consensus repeat-3 domain of recombinant decay-accelerating factor is recognized by Escherichia coli recombinant Dr. adhesin in a model of a cell-cell interaction. J Exp Med 178:2115-2121, 1993
273. Daniels G: Functional aspects of red cell antigens. Blood Rev 13:14-35, 1999
274. Mossakowska D, Dodd I, Pindar W, et al: Structure-activity relationships within the N-terminal short consensus repeats (SCR) of human CR1 (C3b/C4b receptor, CD35): SCR 3 plays a critical role in inhibition of the classical and alternative pathways of complement activation. Eur J Immunol 29:1955-1965, 1999
275. Seya T, Holers VM, Atkinson JP: Purification and functional analysis of the polymorphic variants of the C3b/C4b receptor (CR1) and comparison with H, C4b-binding protein (C4bp), and decay accelerating factor (DAF). J Immunol 135:2661-2667, 1985
276. Klickstein LB, Wong WW, Smith JA, et al: Human C3b/C4b receptor (CRI.). Demonstration of long homologous repeating domains that are composed of the short consensus repeats characteristics of C3/C4 binding proteins. J Exp Med 165:1095-1112, 1987
277. Hourcade D, Liszewski MK; Krych-Goldberg M, et al: Functional domains, structural variations and pathogen interactions of MCP, DAF and CR1. Immunopharmacology 49:103-116, 2000
278. Telen MJ, Green AM: The Inab phenotype: Characterization of the membrane protein and complement regulatory defect. Blood 74:437-441, 1989
279. Tamasauskas D, Powell V, Schawalder A, et al: Localization of Knops system antigens in the long homologous repeats (LHRs) of complement receptor 1. Transfusion 41:1397-1404, 2001
280. Moulds JM, Moulds JJ, Brown M, et al: Antiglobulin testing for CR1-related (Knops/McCoy/Swain-Langley/York) blood group antigens: Negative and weak reactions are caused by variable expression of CR1. Vox Sang 62:230-235, 1992
281. Yoon SH, Fearon DT: Characterization of a soluble form of the C3b/C4b receptor (CR1) in human plasma. J Immunol 134:3332-3338, 1985
282. Rao N, Ferguson DJ, Lee SF, et al: Identification of human erythrocyte blood group antigens on the C3b/C4b receptor. J Immunol 146:3502-3507, 1991
283. Ng YC, Schifferli JA, Walport MJ: Immune complexes and erythrocyte CR1 (complement receptor type 1): Effect of CR1 numbers on binding and release reactions. Clin Exp Immunol 71:481-485, 1988
284. Rowe JA, Moulds JM, Newbold CI, et al: P-falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1. Nature 388:292-295, 1997
285. Moulds JM: Association of blood group antigens with immunologically important proteins, in Garratty G (ed): Immunobiology of Transfusion Medicine. New York, NY, Marcel Dekker, 1994, pp 273-297
286. Rowe PC, McLean RH, Wood RA, et al: Association of homozygous C4B deficiency with bacterial meningitis. J Infect Dis 160:448-451, 1989
287. Poschmann A, Fischer K, Seidl S, et al: ABH receptors and red cell survival in a "Bombay" blood. Immunofluorescence studies by phytohemagglutinins and Helix agglutinins. Vox Sang 27:338-346, 1974
288. Greenwell P: Blood group antigens: Molecules seeking a function? Glycoconj J 14:159-173, 1997
289. Marcus DM, Cass LE: Glycosphingolipids with Lewis blood group activity: Uptake by human erythrocytes. Science 164:553-555, 1969
290. Boren T, Falk P, Roth KA, et al: Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science 262:1892-1895, 1993
291. Ilver D, Arnqvist A, Ögren J, et al: Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 279:373-377, 1998
292. Guruge JL, Falk PG, Lorenz RG, et al: Epithelial attachment alters the outcome of Helicobacter pylori infection. Proc Natl Acad Sci USA 95:3925-3930, 1998
293. Heneghan MA, McCarthy CF, Moran AP: Relationship of blood group determinants on Helicobacter pylori lipopolysaccharide with host Lewis phenotype and inflammatory response. Infect Immun 68:937-941, 2000
294. Garratty G: Blood group antigens as tumor markers, parasitic/bacterial/viral receptors, and their association with immunologically important proteins. Immunol Invest 24:213-232, 1995
295. Brown KE, Anderson SM, Young NS: Erythrocyte P antigen: Cellular receptor for B19 parvovirus. Science 262:114-117, 1993
296. Carper E, Kurtzman GJ: Human parvovirus B19 infection. Curr Opin Hematol 3:111-117, 1996
297. Karlsson KA: Animal glycosphingolipids as membrane attachment sites for bacteria. Ann Rev Biochem 58:309-350, 1989
298. Daniels GL, Levene C, Berrebi A, et al: Human alloantibodies detecting a red cell antigen apparently identical to MER2. Vox Sang 55:161-164, 1988
299. Telen MJ: Erythrocyte blood group antigens: Polymorphisms of functionally important molecules. Semin Hematol 33:302-314, 1996